Delivering excellent products and services
Cardinal Health is a global leader in development, drug delivery technologies, contract manufacturing, packaging and product commercialisation services, serving the worldwide pharmaceutical and biotechnology industries.
It offers a range of services, such as pre-clinical support, API development, analytical services, drug delivery development, clinical manufacturing and packaging services. It has expertise in inhalation development, and can offer innovative cell-line development using its proprietary GPEx® technology.
It provides a wide range of scientific and regulatory consulting services required to obtain marketing approval for drugs, biologics and medical devices in the US, Canadian, Asian and European markets.
Wide-ranging services
Cardinal Health holds more than 1,500 patents and patent applications for drug delivery systems. Its drug delivery technologies include:
- Soft gelatin capsules
- Zydis® fast dissolve dosage form
- EnCirc®, EnVel® and EnSolv® for oral modified release products
- Lyophilisation
- Inhaled technologies
- Topical Microsponge® timed-release system
- DelPouch® unit dose delivery system
It also manufactures traditional oral dose forms, sterile dose forms, and topical and inhaled forms. It produces biologics for pre-clinical and clinical studies.
Cardinal Health designs unique packaging solutions that create shelf presence and improve patient compliance. From cartons to promotional materials to printed inserts and labels, it offers expertise and attention to detail.
It can also provide product and service logistics, distribution support, sample and literature fulfilment, and reimbursement support.
For more information, visit www.cardinal.com/pts.
< Back to Drug Delivery index
< Back to Market Resources index
